HLHui-Min Lu

Hui-Min Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hui-Min Lu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Jianhua Jin

    Wujin Hospital Affiliated with Jiangsu University (The Wujin Clinical College of Xuzhou Medical University), Changzhou, 213017, Jiangsu, China.

    3 shared publications
  • Xinghao Yu

    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, 215123, Jiangsu, China

    3 shared publications
  • Yi Jin

    Wujin Hospital Affiliated with Jiangsu University (The Wujin Clinical College of Xuzhou Medical University), Changzhou, 213017, Jiangsu, China.

    3 shared publications
  • Binjie Zhu

    Wujin Hospital Affiliated with Jiangsu University, Changzhou, 213017, Jiangsu, China

    1 shared publication
  • Guan-Min Yan

    Department of Outpatient and Emergency, First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China

    1 shared publication
  • Jie Gu

    Department of Outpatient and Emergency, First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China

    1 shared publication

Latest Publications

  • Gut-reproduction axis: genome-wide pleiotropic and prospective evidence linking inflammatory bowel disease with gynecological disorders

    by Zhenxing Jiang, Xinghao Yu, Huimin Lu, Mingzhu Su, Xiaomin Li, Qin Su, Lijuan Wang, Jianhua Jin, Yi Jin

    We aimed to explore shared genetic architectures and potential causal associations between inflammatory bowel disease (IBD) and gynecological diseases, including ovarian cysts (OC), pelvic inflammatory disease (PID), and endometriosis (EMs), and to evaluate whether the findings are consistent with a gut-reproductive connection. We used genome-wide association study (GWAS) data to assess genetic correlation between IBD and gynecological diseases. Cross-trait pleiotropic loci and genes were identified using PLACO, colocalization, and functional annotation analyses. Stratified LDSC and HyPrColoc were applied to explore immune-related enrichment and colocalized immune traits. Mendelian randomization (MR) was used to assess bidirectional causal effects, and UK Biobank cohort data were analyzed using Cox proportional hazards models. Genetic correlation analyses supported shared genetic architecture between IBD and gynecological diseases. Pleiotropy and colocalization analyses highlighted representative loci including 6q22.33, 9q34, 1q21.3, 16q12.1, 6q27, and 1q32.1, with enrichment of immune-related pathways such as IL-23 and JAK-STAT signaling, particularly in the colon, small intestine, and spleen. Colocalization signals involving Ruminococcus gauvreauii suggested overlap with microbial abundance traits. MR analyses provided the most consistent evidence for directional associations from IBD and CD to PID, whereas UK Biobank analyses supported broader bidirectional associations, particularly for OC and PID. This study identifies shared genetic loci, immune-related pathways, and complementary causal and observational associations between IBD and gynecological conditions. These findings support the gut-reproductive axis as a conceptual framework for future mechanistic investigation.

  • Open Access

    Convergent Multistage Evidence Implicates the CCR2–Artemin Immune–Inflammation Axis in Acute Myeloid Leukemia

    by Yi Jin, Hui-Min Lu, Xing-Hao Yu, Ming-Zhu Su, Jun Li, Xiao-Min Li, Jian-Hua Jin, Li-Ting Zhang, Yue Wang

    Background: The immune system and inflammatory proteins influence hematologic malignancies, but causal links with immune cell phenotypes are unclear. Methods: We applied a prespecified, multistage workflow: two‐sample and multivariable Mendelian randomization (MVMR; 731 immune traits across 12 hematologic cancers), two‐step mediation Mendelian randomization (MR) of 91 circulating inflammatory proteins, MAGMA/FUMA gene and pathway enrichment, and external validation with trait‐specific genetic risk scores (GRSs) in UK Biobank (UKB). We then performed CCR2 perturbation assays in human monocytic leukemia cell line (THP‐1) and immortalized bone marrow‐derived macrophage (IBMDM) cells with artemin ( ARTN ) mRNA readouts and examined proteomic correlations for ARTN using the Olink inflammatory panel. Results: Eight immune phenotypes showed FDR–significant causal associations with malignancy, seven of which remained independent in MVMR. In acute myeloid leukemia (AML), CCR2 on CD62L + myeloid dendritic cells (DCs) was associated with lower risk, whereas BAFF-R and CD19 on transitional B cells were associated with higher risk, CD19 on IgD − CD38^dim B cells was associated with chronic myeloid leukemia (CML), and HLA‐DR + NK cells were protective in non‐Hodgkin lymphoma (NHL). Mediation MR identified three protein mediators— CD40L , IL-33 , and ARTN , with ARTN mediating the CCR2 ‐AML association. GRS analyses reproduced risk directions, most prominently the protective CCR2 –AML association. In THP‐1 and IBMDM models, CCR2 inhibition or knockdown increased ARTN mRNA expression, functionally supporting a CCR2 → ARTN regulatory relationship. Proteomic correlations positioned ARTN with immune‐metabolic proteins ( CLEC6A , SIGLEC6 , NPC2 , and MTHFD2 ). Pathway analyses highlighted membrane‐proximal processes (external plasma membrane and IgG binding) and a 16p11.2 signal. Conclusion: This integrative analysis identified CCR2 – ARTN as a mechanistically supported immune‐inflammation axis contributing to AML risk, offering a potential therapeutic target and warrants direct validation in primary CD62L + myeloid DCs.


  • Prospective evidence for the gut–bone axis in osteoporotic fractures: Insights from genetic prediction and metabolite mediators

    by Binjie Zhu, Xinghao Yu, Huimin Lu, Mingzhu Su, Xiaomin Li, Jianhua Jin, Yongmin Yan, Yi Jin


  • Assessing the causal relationship between immune traits and systemic lupus erythematosus by bi-directional Mendelian randomization analysis

    by Jie Gu, Guan-Min Yan, Xiao-Lin Kong, Yin-Ying Zhang, Li-Hong Huang, Hui-Min Lu

    Previous studies have observed relationships between immune cells and systemic lupus erythematosus (SLE), but their causal links remain undetermined. Based on the public available genome-wide association studies (GWAS) summary statistics, we conducted two-sample Mendelian randomization (MR) to evaluate the associations between 731 immune phenotypes and SLE pairs. Pairwise pleiotropy analysis was performed to identify pleiotropic genes for significant immunophenotype–SLE pairs. A comprehensive gene function analysis was undertaken to explore the mechanisms of immune cells in SLE. By using the instrumental variables extracted from GWAS data, we observed that increased levels of five immune phenotypes were causally associated with SLE risk (FDR < 0.05), that were CD20 on IgD+ CD38− naïve, BAFF-R on IgD+ CD38dim, CD39+ secreting Treg AC, CD14− CD16+ monocyte AC, and HLA DR on CD14+ monocyte. Pairwise gene-based analyses identified a total of 38 pleiotropic genes for 5 significant pairs identified and gene set enrichment analysis revealed the involvement of the identified pleiotropic genes in complex pathways (i.e., systemic lupus erythematosus, an integral component of luminal side of endoplasmic reticulum membrane, C-type lectin receptor signaling pathway and regulation of hormone secretion). This study demonstrates that the immune response influences the progression of SLE in a complex pattern. These findings greatly improve our understanding of the interaction between immune response and SLE risk and also aid in the design of therapeutic strategies from an immunological perspective.